Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer's point-of-view

Executive Summary

"You realize of course that wholesalers play games with us here, wanting to take more inventory in advance of price increases and then kind of hiding that from us for the next few months," Pfizer President Henry McKinnell, PhD, explained to investors. "We think that at this point, five or six months after our price increase, that sort of nonsense has smoothed out...Inventory should be in balance." The timing of the trade stocking patterns allowed Pfizer to post an unusually strong quarter for the January-March period while closing out the hostile takeover of Warner-Lambert
Advertisement

Related Content

Wholesaler Forward-Buying Is Back, J&J Says; Rx Price Increases Pick Up
Wholesaler Forward-Buying Is Back, J&J Says; Rx Price Increases Pick Up
Advertisement
UsernamePublicRestriction

Register

PS036434

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel